Covid-19 Impact on Global Regenerative Drugs Market Size, Status and Forecast 2020-2026

June 2020 | 92 pages | ID: C4596F729737EN
QYResearch

Abstracts

This report focuses on the global Regenerative Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Regenerative Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Stryker
• Zimmer Biomet Holdings
• Medtronic
• Athersys
• STEMCELL Technologies
• Organogenesis
• Integra Lifesciences
• Acelity
• Isto Biologics
• CryoLife

Market segment by Type, the product can be split into

• Synthetic Material
• Biologically Derived Material
• Genetically Engineered Material
• Others

Market segment by Application, split into

• Cardiovascular
• Dermatology
• Musculoskeletal
• Neurology
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Regenerative Drugs status, future forecast, growth opportunity, key market and key players.
• To present the Regenerative Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Regenerative Drugs are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Regenerative Drugs Revenue
1.4 Market Analysis by Type
  1.4.1 Global Regenerative Drugs Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Synthetic Material
  1.4.3 Biologically Derived Material
  1.4.4 Genetically Engineered Material
  1.4.5 Others
1.5 Market by Application
  1.5.1 Global Regenerative Drugs Market Share by Application: 2020 VS 2026
  1.5.2 Cardiovascular
  1.5.3 Dermatology
  1.5.4 Musculoskeletal
  1.5.5 Neurology
  1.5.6 Others
1.6 Coronavirus Disease 2019 (Covid-19): Regenerative Drugs Industry Impact
  1.6.1 How the Covid-19 is Affecting the Regenerative Drugs Industry
    1.6.1.1 Regenerative Drugs Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Regenerative Drugs Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Regenerative Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Regenerative Drugs Market Perspective (2015-2026)
2.2 Regenerative Drugs Growth Trends by Regions
  2.2.1 Regenerative Drugs Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Regenerative Drugs Historic Market Share by Regions (2015-2020)
  2.2.3 Regenerative Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Regenerative Drugs Market Growth Strategy
  2.3.6 Primary Interviews with Key Regenerative Drugs Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Regenerative Drugs Players by Market Size
  3.1.1 Global Top Regenerative Drugs Players by Revenue (2015-2020)
  3.1.2 Global Regenerative Drugs Revenue Market Share by Players (2015-2020)
  3.1.3 Global Regenerative Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Regenerative Drugs Market Concentration Ratio
  3.2.1 Global Regenerative Drugs Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Regenerative Drugs Revenue in 2019
3.3 Regenerative Drugs Key Players Head office and Area Served
3.4 Key Players Regenerative Drugs Product Solution and Service
3.5 Date of Enter into Regenerative Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Regenerative Drugs Historic Market Size by Type (2015-2020)
4.2 Global Regenerative Drugs Forecasted Market Size by Type (2021-2026)

5 REGENERATIVE DRUGS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Regenerative Drugs Market Size by Application (2015-2020)
5.2 Global Regenerative Drugs Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Regenerative Drugs Market Size (2015-2020)
6.2 Regenerative Drugs Key Players in North America (2019-2020)
6.3 North America Regenerative Drugs Market Size by Type (2015-2020)
6.4 North America Regenerative Drugs Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Regenerative Drugs Market Size (2015-2020)
7.2 Regenerative Drugs Key Players in Europe (2019-2020)
7.3 Europe Regenerative Drugs Market Size by Type (2015-2020)
7.4 Europe Regenerative Drugs Market Size by Application (2015-2020)

8 CHINA

8.1 China Regenerative Drugs Market Size (2015-2020)
8.2 Regenerative Drugs Key Players in China (2019-2020)
8.3 China Regenerative Drugs Market Size by Type (2015-2020)
8.4 China Regenerative Drugs Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Regenerative Drugs Market Size (2015-2020)
9.2 Regenerative Drugs Key Players in Japan (2019-2020)
9.3 Japan Regenerative Drugs Market Size by Type (2015-2020)
9.4 Japan Regenerative Drugs Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Regenerative Drugs Market Size (2015-2020)
10.2 Regenerative Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Regenerative Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Regenerative Drugs Market Size by Application (2015-2020)

11 INDIA

11.1 India Regenerative Drugs Market Size (2015-2020)
11.2 Regenerative Drugs Key Players in India (2019-2020)
11.3 India Regenerative Drugs Market Size by Type (2015-2020)
11.4 India Regenerative Drugs Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Regenerative Drugs Market Size (2015-2020)
12.2 Regenerative Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Regenerative Drugs Market Size by Type (2015-2020)
12.4 Central & South America Regenerative Drugs Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Stryker
  13.1.1 Stryker Company Details
  13.1.2 Stryker Business Overview and Its Total Revenue
  13.1.3 Stryker Regenerative Drugs Introduction
  13.1.4 Stryker Revenue in Regenerative Drugs Business (2015-2020))
  13.1.5 Stryker Recent Development
13.2 Zimmer Biomet Holdings
  13.2.1 Zimmer Biomet Holdings Company Details
  13.2.2 Zimmer Biomet Holdings Business Overview and Its Total Revenue
  13.2.3 Zimmer Biomet Holdings Regenerative Drugs Introduction
  13.2.4 Zimmer Biomet Holdings Revenue in Regenerative Drugs Business (2015-2020)
  13.2.5 Zimmer Biomet Holdings Recent Development
13.3 Medtronic
  13.3.1 Medtronic Company Details
  13.3.2 Medtronic Business Overview and Its Total Revenue
  13.3.3 Medtronic Regenerative Drugs Introduction
  13.3.4 Medtronic Revenue in Regenerative Drugs Business (2015-2020)
  13.3.5 Medtronic Recent Development
13.4 Athersys
  13.4.1 Athersys Company Details
  13.4.2 Athersys Business Overview and Its Total Revenue
  13.4.3 Athersys Regenerative Drugs Introduction
  13.4.4 Athersys Revenue in Regenerative Drugs Business (2015-2020)
  13.4.5 Athersys Recent Development
13.5 STEMCELL Technologies
  13.5.1 STEMCELL Technologies Company Details
  13.5.2 STEMCELL Technologies Business Overview and Its Total Revenue
  13.5.3 STEMCELL Technologies Regenerative Drugs Introduction
  13.5.4 STEMCELL Technologies Revenue in Regenerative Drugs Business (2015-2020)
  13.5.5 STEMCELL Technologies Recent Development
13.6 Organogenesis
  13.6.1 Organogenesis Company Details
  13.6.2 Organogenesis Business Overview and Its Total Revenue
  13.6.3 Organogenesis Regenerative Drugs Introduction
  13.6.4 Organogenesis Revenue in Regenerative Drugs Business (2015-2020)
  13.6.5 Organogenesis Recent Development
13.7 Integra Lifesciences
  13.7.1 Integra Lifesciences Company Details
  13.7.2 Integra Lifesciences Business Overview and Its Total Revenue
  13.7.3 Integra Lifesciences Regenerative Drugs Introduction
  13.7.4 Integra Lifesciences Revenue in Regenerative Drugs Business (2015-2020)
  13.7.5 Integra Lifesciences Recent Development
13.8 Acelity
  13.8.1 Acelity Company Details
  13.8.2 Acelity Business Overview and Its Total Revenue
  13.8.3 Acelity Regenerative Drugs Introduction
  13.8.4 Acelity Revenue in Regenerative Drugs Business (2015-2020)
  13.8.5 Acelity Recent Development
13.9 Isto Biologics
  13.9.1 Isto Biologics Company Details
  13.9.2 Isto Biologics Business Overview and Its Total Revenue
  13.9.3 Isto Biologics Regenerative Drugs Introduction
  13.9.4 Isto Biologics Revenue in Regenerative Drugs Business (2015-2020)
  13.9.5 Isto Biologics Recent Development
13.10 CryoLife
  13.10.1 CryoLife Company Details
  13.10.2 CryoLife Business Overview and Its Total Revenue
  13.10.3 CryoLife Regenerative Drugs Introduction
  13.10.4 CryoLife Revenue in Regenerative Drugs Business (2015-2020)
  13.10.5 CryoLife Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Regenerative Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Regenerative Drugs Revenue
Table 3. Ranking of Global Top Regenerative Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Regenerative Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Synthetic Material
Table 6. Key Players of Biologically Derived Material
Table 7. Key Players of Genetically Engineered Material
Table 8. Key Players of Others
Table 9. COVID-19 Impact Global Market: (Four Regenerative Drugs Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Regenerative Drugs Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Regenerative Drugs Players to Combat Covid-19 Impact
Table 14. Global Regenerative Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Regenerative Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Regenerative Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Regenerative Drugs Market Share by Regions (2015-2020)
Table 18. Global Regenerative Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Regenerative Drugs Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Regenerative Drugs Market Growth Strategy
Table 24. Main Points Interviewed from Key Regenerative Drugs Players
Table 25. Global Regenerative Drugs Revenue by Players (2015-2020) (Million US$)
Table 26. Global Regenerative Drugs Market Share by Players (2015-2020)
Table 27. Global Top Regenerative Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Regenerative Drugs as of 2019)
Table 28. Global Regenerative Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Regenerative Drugs Product Solution and Service
Table 31. Date of Enter into Regenerative Drugs Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Regenerative Drugs Market Size by Type (2015-2020) (Million US$)
Table 34. Global Regenerative Drugs Market Size Share by Type (2015-2020)
Table 35. Global Regenerative Drugs Revenue Market Share by Type (2021-2026)
Table 36. Global Regenerative Drugs Market Size Share by Application (2015-2020)
Table 37. Global Regenerative Drugs Market Size by Application (2015-2020) (Million US$)
Table 38. Global Regenerative Drugs Market Size Share by Application (2021-2026)
Table 39. North America Key Players Regenerative Drugs Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Regenerative Drugs Market Share (2019-2020)
Table 41. North America Regenerative Drugs Market Size by Type (2015-2020) (Million US$)
Table 42. North America Regenerative Drugs Market Share by Type (2015-2020)
Table 43. North America Regenerative Drugs Market Size by Application (2015-2020) (Million US$)
Table 44. North America Regenerative Drugs Market Share by Application (2015-2020)
Table 45. Europe Key Players Regenerative Drugs Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Regenerative Drugs Market Share (2019-2020)
Table 47. Europe Regenerative Drugs Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Regenerative Drugs Market Share by Type (2015-2020)
Table 49. Europe Regenerative Drugs Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Regenerative Drugs Market Share by Application (2015-2020)
Table 51. China Key Players Regenerative Drugs Revenue (2019-2020) (Million US$)
Table 52. China Key Players Regenerative Drugs Market Share (2019-2020)
Table 53. China Regenerative Drugs Market Size by Type (2015-2020) (Million US$)
Table 54. China Regenerative Drugs Market Share by Type (2015-2020)
Table 55. China Regenerative Drugs Market Size by Application (2015-2020) (Million US$)
Table 56. China Regenerative Drugs Market Share by Application (2015-2020)
Table 57. Japan Key Players Regenerative Drugs Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Regenerative Drugs Market Share (2019-2020)
Table 59. Japan Regenerative Drugs Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Regenerative Drugs Market Share by Type (2015-2020)
Table 61. Japan Regenerative Drugs Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Regenerative Drugs Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Regenerative Drugs Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Regenerative Drugs Market Share (2019-2020)
Table 65. Southeast Asia Regenerative Drugs Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Regenerative Drugs Market Share by Type (2015-2020)
Table 67. Southeast Asia Regenerative Drugs Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Regenerative Drugs Market Share by Application (2015-2020)
Table 69. India Key Players Regenerative Drugs Revenue (2019-2020) (Million US$)
Table 70. India Key Players Regenerative Drugs Market Share (2019-2020)
Table 71. India Regenerative Drugs Market Size by Type (2015-2020) (Million US$)
Table 72. India Regenerative Drugs Market Share by Type (2015-2020)
Table 73. India Regenerative Drugs Market Size by Application (2015-2020) (Million US$)
Table 74. India Regenerative Drugs Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Regenerative Drugs Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Regenerative Drugs Market Share (2019-2020)
Table 77. Central & South America Regenerative Drugs Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Regenerative Drugs Market Share by Type (2015-2020)
Table 79. Central & South America Regenerative Drugs Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Regenerative Drugs Market Share by Application (2015-2020)
Table 81. Stryker Company Details
Table 82. Stryker Business Overview
Table 83. Stryker Product
Table 84. Stryker Revenue in Regenerative Drugs Business (2015-2020) (Million US$)
Table 85. Stryker Recent Development
Table 86. Zimmer Biomet Holdings Company Details
Table 87. Zimmer Biomet Holdings Business Overview
Table 88. Zimmer Biomet Holdings Product
Table 89. Zimmer Biomet Holdings Revenue in Regenerative Drugs Business (2015-2020) (Million US$)
Table 90. Zimmer Biomet Holdings Recent Development
Table 91. Medtronic Company Details
Table 92. Medtronic Business Overview
Table 93. Medtronic Product
Table 94. Medtronic Revenue in Regenerative Drugs Business (2015-2020) (Million US$)
Table 95. Medtronic Recent Development
Table 96. Athersys Company Details
Table 97. Athersys Business Overview
Table 98. Athersys Product
Table 99. Athersys Revenue in Regenerative Drugs Business (2015-2020) (Million US$)
Table 100. Athersys Recent Development
Table 101. STEMCELL Technologies Company Details
Table 102. STEMCELL Technologies Business Overview
Table 103. STEMCELL Technologies Product
Table 104. STEMCELL Technologies Revenue in Regenerative Drugs Business (2015-2020) (Million US$)
Table 105. STEMCELL Technologies Recent Development
Table 106. Organogenesis Company Details
Table 107. Organogenesis Business Overview
Table 108. Organogenesis Product
Table 109. Organogenesis Revenue in Regenerative Drugs Business (2015-2020) (Million US$)
Table 110. Organogenesis Recent Development
Table 111. Integra Lifesciences Company Details
Table 112. Integra Lifesciences Business Overview
Table 113. Integra Lifesciences Product
Table 114. Integra Lifesciences Revenue in Regenerative Drugs Business (2015-2020) (Million US$)
Table 115. Integra Lifesciences Recent Development
Table 116. Acelity Business Overview
Table 117. Acelity Product
Table 118. Acelity Company Details
Table 119. Acelity Revenue in Regenerative Drugs Business (2015-2020) (Million US$)
Table 120. Acelity Recent Development
Table 121. Isto Biologics Company Details
Table 122. Isto Biologics Business Overview
Table 123. Isto Biologics Product
Table 124. Isto Biologics Revenue in Regenerative Drugs Business (2015-2020) (Million US$)
Table 125. Isto Biologics Recent Development
Table 126. CryoLife Company Details
Table 127. CryoLife Business Overview
Table 128. CryoLife Product
Table 129. CryoLife Revenue in Regenerative Drugs Business (2015-2020) (Million US$)
Table 130. CryoLife Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Regenerative Drugs Market Share by Type: 2020 VS 2026
Figure 2. Synthetic Material Features
Figure 3. Biologically Derived Material Features
Figure 4. Genetically Engineered Material Features
Figure 5. Others Features
Figure 6. Global Regenerative Drugs Market Share by Application: 2020 VS 2026
Figure 7. Cardiovascular Case Studies
Figure 8. Dermatology Case Studies
Figure 9. Musculoskeletal Case Studies
Figure 10. Neurology Case Studies
Figure 11. Others Case Studies
Figure 12. Regenerative Drugs Report Years Considered
Figure 13. Global Regenerative Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Regenerative Drugs Market Share by Regions: 2020 VS 2026
Figure 15. Global Regenerative Drugs Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Regenerative Drugs Market Share by Players in 2019
Figure 18. Global Top Regenerative Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Regenerative Drugs as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Regenerative Drugs Revenue in 2019
Figure 20. North America Regenerative Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Regenerative Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Regenerative Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Regenerative Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Regenerative Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Regenerative Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Regenerative Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Stryker Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Stryker Revenue Growth Rate in Regenerative Drugs Business (2015-2020)
Figure 29. Zimmer Biomet Holdings Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Zimmer Biomet Holdings Revenue Growth Rate in Regenerative Drugs Business (2015-2020)
Figure 31. Medtronic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Medtronic Revenue Growth Rate in Regenerative Drugs Business (2015-2020)
Figure 33. Athersys Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Athersys Revenue Growth Rate in Regenerative Drugs Business (2015-2020)
Figure 35. STEMCELL Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. STEMCELL Technologies Revenue Growth Rate in Regenerative Drugs Business (2015-2020)
Figure 37. Organogenesis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Organogenesis Revenue Growth Rate in Regenerative Drugs Business (2015-2020)
Figure 39. Integra Lifesciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Integra Lifesciences Revenue Growth Rate in Regenerative Drugs Business (2015-2020)
Figure 41. Acelity Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Acelity Revenue Growth Rate in Regenerative Drugs Business (2015-2020)
Figure 43. Isto Biologics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Isto Biologics Revenue Growth Rate in Regenerative Drugs Business (2015-2020)
Figure 45. CryoLife Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. CryoLife Revenue Growth Rate in Regenerative Drugs Business (2015-2020)
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed